Chemical structure of aztreonam

Find information on thousands of medical conditions and prescription drugs.

Aztreonam

Aztreonam is a monocyclic beta-lactam antibiotic (a monobactam) originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is useful against gram-negative bacterial pathogens. It is not used to treat colds, viral or flu infections.

It has no useful activity against gram-positive bacteria or anaerobes, but has very broad spectrum against gram-negative aerobes, including Pseudomonas aeruginosa.

A

Acetylcholine chloride

Acetyldigitoxin

Alvircept sudotox

Aminocaproic acid

Aminoglutethimide

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Carbapenems and monobactams: Imipenem, meropenem, and aztreonam : An article from: Mayo Clinic Proceedings $20.00			Strategies for Pharmacokinetic Optimization of Continuous Infusion Therapy of Ceftazidime and Aztreonam in Patients with Cystic Fibrosis $76.86

		Anti-infectives. (Drug, Pregnancy, and Lactation).(Brief Article) : An article from: Family Practice News $5.95


	Aztreonam for treatment of traveler's diarrhea - Tips from Other Journals Although trimethoprim-sulfamethoxazole is the standard treatment for traveler's diarrhea caused by bacterial infection, trimethoprim-resistant bacteria ... From American Family Physician, 9/1/92

	Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended Background & objectives: Identifying organisms that harbour extended spectrum beta lactamases (ESBLs) is a major challenge for a diagnostic clinical microbiology ... From Indian Journal of Medical Research, 10/1/05 by Manchanda, Vikas

	FDA approves Tygacil for the treatment of complicated skin and skin structure infections The FDA recently approved Tygacil for the intravenous treatment of complicated skin and skin structure infections, including infected burns, deep soft ... From Journal of Drugs in Dermatology, 9/1/05

	AmpC [beta]-lactamase producing bacterial isolates from Kolkata hospital Background & objectives: The widespread use Î²-lactam antibiotics has lead to the development of resistance to this group of antibiotics in bacterial pathogens ... From Indian Journal of Medical Research, 9/1/05 by Arora, Suranjana

	Detection of metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients Background & objectives: Metallo betalactamase (MBL)-mediated resistance to carbapenems is an emerging threat in hospital isolates of Pseudomonas aeruginosa. From Indian Journal of Medical Research, 8/1/05 by V, Hemalatha

	Extended-spectrum [beta]-lactamase-producing flora in healthy persons To the Editor: Extended-spectrum [beta]-lactamase (ESBL) producing gram-negative bacilli are endemic in hospitals. In intensive care units, 2% prevalence ... From Emerging Infectious Diseases, 6/1/05 by Camilla Rodrigues

	Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan We report the prevalence and characteristics of Salmonella strains resistant to ciprofloxacin and extended-spectrum cephalosporins in Taiwan from January ... From Emerging Infectious Diseases, 6/1/05 by Jing-Jou Yan

	Metallo-[beta]-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area Sir, Pseudomonas aeruginosa exhibits resistance to a variety of antimicrobials including beta lactams. Carbapenems are often used as antibiotics for treatment ... From Indian Journal of Medical Research, 5/1/05 by Mendiratta, D K

Home

Contact

Resources

ebay